Conrad Wang, MD
Conrad joined HealthQuest in 2023 as a Partner focused on the Tactical Opportunities Fund. Conrad has nearly two decades of healthcare investing experience, ranging from seed investing and company formation to structured growth capital for commercial stage companies. He has been an investor at OrbiMed, Healthcare Royalty Partners, and Three Arch Partners where he made over thirty investments in medical device, healthcare services and therapeutics companies, resulting in 13 M&A exits and five IPOs, and has served on the board of directors of 10 private companies. He has also led corporate development teams at Medtronic, a Fortune 500 medical device company, executing M&A and licensing transactions, private-public partnerships and venture investments.
Conrad is trained as a physician, scientist and engineer, and completed his post-graduate training at the Harvard Combined Orthopaedic Residency Program, where he was editor-in-chief of the Harvard Orthopaedic Journal and published multiple peer-reviewed basic science and clinical papers. He earned his undergraduate degree from MIT in mechanical engineering and biology, where he was awarded membership in Tau Beta Pi and Pi Tau Sigma honor societies, his MD from the Harvard-MIT Division of Health Sciences and Technology (HST) at Harvard Medical School, and his MBA from Harvard Business School, graduating as a Baker Scholar (top 5%). Conrad enjoys spending time with his wife and three children, playing golf, alpine skiing and classical piano.
